Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia.

ABSTRACT

BACKGROUND: Diagnosis of tuberculosis (TB) remains difficult, particularly in resource-limited settings. The development of nucleic acid-based tests for detection of Mycobacterium tuberculosis complex (MTBC) has significantly increased sensitivity compared to conventional smear microscopy and provides results within a matter of hours compared to weeks for the current gold-standard, liquid culture. METHODS: In this study we performed side-by-side comparison of mycobacterial detection assays on sputum samples from 285 subjects presenting with symptoms suggestive of TB in The Gambia and a cross-sectional cohort of 156 confirmed TB patients with a median of 2 months of treatment. A novel assay, Loop-Mediated Amplification test for TB (TB-LAMP), was compared to smear microscopy, MGIT culture and GeneXpert MTB/RIF for all samples. RESULTS: When culture was used as the reference standard, we found an overall sensitivity for TB-LAMP of 99% (95% CI 94.5-99.8) and specificity of 94% (95% CI 89.3-96.7). When latent class analysis was performed, TB-LAMP had 98.6% (95% CI 95.9-100) sensitivity and 99% (95% CI 98.2-100) specificity compared to 91.1% (95% CI 86.1-96) sensitivity and 100% (95% CI 98.2-100) specificity for MGIT culture. GeneXpert had the highest sensitivity 99.1% (95% CI 97.1-100) but the lowest specificity 96% (95% CI 92.6-98.3). Both TB-LAMP and GeneXpert showed high sensitivity and specificity regardless of age or strain of infection. CONCLUSION: Our findings show the diagnostic utility of both GeneXpert and TB-LAMP in The Gambia. Whilst TB-LAMP requires less infrastructure, it is unable to detect drug-resistant patterns and therefore would be most suitable as a screening test for new TB cases in peripheral health clinics.